Quell relief
Jump to navigation
Jump to search
| QUELL RELIEF | |
|---|---|
|
|
| Category | Therapeutic wearables |
| Developer | NeuroMetrix |
| Announced | Oct 2015 |
| Released | Consumers: 2015 |
| Price | 249 USD |
| Weight | 62 g |
| Dimensions | 98 x 74 x 11 mm |
| Controls | smartphone |
| Standalone[1] | |
| https://www.quellrelief.com/product | |
Contents
Main characteristics
Purpose
Quell wearable is device designated for treatment of chronic pain. It works on principle of transcutaneous electrical nerve stimulation, which causes release of endogenous opiates affecting pain relief.
Company & People
Important Dates
1965 - Melzack and Wall proposed first conceptual model for mechanism which could lead to pain relief
1970s - Developement of TENS (Transcutaneous electrical nerve stimulation)
Ethical Issues
Health Risks
No health risks are known. Usage is 100% drug free, with clearance by FDA (Food and Drug Administration)
Enhancement/Therapy/Treatment
Quell wearable device has primarily therapeutical function. It was developed on purpose to palliate chronical pain which basically has origin in these four diseases:
Public & Media Impact and Presentation
Public Policy
Related Technologies, Project or Scientific Research
References
- ↑ Shows if the device is a standalone wearable computer or if it needs to be connected to a processing unit to function.
